Stockreport

IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference

IN8bio, Inc.  (INAB) 
PDF NEW YORK, Aug. 29, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell th [Read more]